Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05565313 · ClinicalTrials.gov registry record
Predicting Radiological Extranodal Extension in Oropharyngeal Carcinoma Patients Using AI
A clinical trial of Head and Neck Carcinoma, sponsored by Maastricht Radiation Oncology.
- Active
- Registry status
- 900
- Enrollment target
- 3
- Study locations
NCT05565313 is a study of Head and Neck Carcinoma that is active but no longer recruiting, run by Maastricht Radiation Oncology. The registered enrollment target is 900 participants, above the 383-participant average among 30 other Head and Neck Carcinoma trials with a reported enrollment target (135% higher). The trial reports 3 study locations across 3 states.
The verdict
NCT05565313, a study of Head and Neck Carcinoma, is active but no longer recruiting, sponsored by Maastricht Radiation Oncology.
- ACTIVE NOT RECRUITING
- Registry status
- 900 participants
- Enrollment target
- 3
- Study locations
Study Summary
Development and validation of a model that predicts rENE from radiological imaging using annotated / labeled scans by means of deep learning
Conditions Studied
Study Locations (3)
Massachusetts
- Harvard Medical School and clinical faculty at Dana-Farber Cancer Institute/Brigham and Women's Hospital - Boston
Ontario
- Princess Margaret Cancer Centre - Toronto
Limburg
- Maastro - Maastricht
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2022-03-22 |
| Est. Completion | 2026-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05565313
The ClinicalTrials.gov registry entry for NCT05565313 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 900 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 383-participant average among 30 other Head and Neck Carcinoma trials with a reported enrollment target (135% higher). The listed sponsor is Maastricht Radiation Oncology, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Head and Neck Carcinoma appearing as the primary indexed condition, and to 0 interventions.
NCT05565313 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Massachusetts, Ontario, Limburg.
Frequently Asked Questions
What is clinical trial NCT05565313 about?
NCT05565313 is a clinical study titled "Predicting Radiological Extranodal Extension in Oropharyngeal Carcinoma Patients Using AI". Development and validation of a model that predicts rENE from radiological imaging using annotated / labeled scans by means of deep learning
What is the current status of trial NCT05565313?
This trial is currently active not recruiting. The enrollment target is 900 participants. The study started on 2022-03-22. Estimated completion is 2026-08-01.
What conditions does trial NCT05565313 study?
This clinical trial studies the following conditions: Head and Neck Carcinoma.
Who is sponsoring clinical trial NCT05565313?
This trial is sponsored by Maastricht Radiation Oncology, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05565313 being conducted?
This trial has 3 study locations across Massachusetts, Ontario, Limburg. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head and Neck Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
RECRUITING · Phase 1
-
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
RECRUITING · Phase 1
-
A Financial Intervention (Financial Compass) to Identify and Address Financial Hardship Among Head and Neck Cancer Patients, Financial Compass Trial
RECRUITING · NA
-
Tongue-out Radiation Therapy (TORT) for the Mitigation of Radiotherapy-related Toxicities in Patients With Head and Neck Cancer
RECRUITING · NA
-
Cancer Genetic Testing in Ethnic Populations
RECRUITING · NA
-
Evaluation of Radiobiological Effects in Skin Toxicities Head and Neck Cancer Patients With PBS Proton Therapy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.